Share Prices & Company Research

Market News

04 Feb 2021 | 15:54

Deutsche Bank cuts GlaxoSmithKline to 'sell', says valuation alone is not enough

(Sharecast News) - Analysts at Deutsche Bank downgraded their recommendation for shares of GlaxoSmithKline to "sell" following the UK drug giant's latest quarterly update.

In a research note sent to clients, they explained that GSK's fourth quarter financials and outlook had been weaker than their already cautious stance.

Deutsche had previously had the shares at 'hold'. The broker also cut its target price on the stock from 1,400.0p to 1,150.0p.

A further proviso was that valuation was not enough to justify an investment and in any case offered limited support, given how shares in several of GSK's large global peers were also trading on single digit valuation multiples.

In order to be just "vaguely constuctive", one one need to believe that growth was set to rebound in 2022 and that the risk-reward trade-off around the catalyst for the firm's interim research and development pipeline was "attractive".

Deutsche said its confidence was "limited" on both fronts.

"2022 confidence relies on growth being deferred rather than lost, which is non-obvious (we can easily envisage a scenario in which pandemic disruption sees launches/Shingrix constrained into 2022 [...])."
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 14th May 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.